English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18054/20253 (89%)
Visitors : 24288448      Online Users : 82
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/32174

    標題: Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case-control study
    作者: Wang, Hsien-Yi
    Huang, Charles Lung-Cheng
    Feng, I. Jung
    Tsuang, Hui-Chun
    貢獻者: Chi Mei Med Ctr, Div Nephrol
    Chia Nan Univ Pharm & Sci, Coll Leisure & Recreat Management, Dept Sport Management
    Chi Mei Med Ctr, Div Psychiat
    Chia Nan Univ Pharm & Sci, Dept Social Work
    Chi Mei Med Ctr, Dept Med Res
    Chang Jung Christian Univ, Ctr Gen Educ
    關鍵字: New-Generation Antipsychotics
    Atypical Antipsychotics
    Mood Stabilizers
    日期: 2018-05
    上傳時間: 2019-11-15 15:43:46 (UTC+8)
    摘要: Objectives The study aims to compare the risk of chronic kidney diseases (CKDs) between patients with schizophrenia using first and second-generation antipsychotics. Setting Datasets of 2000-2013 National Health Insurance in Taiwan were used. Participants The National Health Insurance reimbursement claims data have been transferred to and managed by the National Health Research Institute in Taiwan since 1996. We used the Psychiatric Inpatient Medical Claims database, a subset of the National Health Insurance Research Database, comprising a cohort of patients hospitalised for psychiatric disorders between 2000 and 2013 (n=267807). The database included patients with at least one psychiatric inpatient record and one discharge diagnosis of mental disorders coded by the International Classification of Diseases, Ninth Revision (ICD-9) codes 290-319. The age of patients at first admission was restricted to 18-65 years. Primary outcome CKD (ICD-9 code 582, 583, 585, 586, 588) requiring hospitalisation or three outpatient visits. The diagnosis of CKD follows the criteria of 'Kidney Disease: Improving Global Outcomes' in Taiwan. CKD is defined as a kidney damage as albumin-to-creatinine ratio >30 mg/g in two of three spot urine specimens or glomerular filtration rate <60 mUmin/1.73 m(2) for 3 months or more. Results We found that the risks for CKD were higher for those who used second-generation antipsychotics (SGAs) longer cumulatively than those who did not. Using nonusers, patients did not have any SGA records, as reference group, the risks for CKD comparing those using SGAs for 90 to 180 days with non-users and those using SGAs for more than 1000 days were 1.42 (1.06-1.91) and 1.30 (1.13-1.51), respectively. Conclusions The current study suggests the relationship between using SGAs and risk of CKD.
    link: http://dx.doi.org/10.1136/bmjopen-2017-019868
    關聯: Journal of Electronic Commerce Research, v.8, n.5, e019868
    Appears in Collections:[運動管理系] 期刊論文
    [社會工作系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    10.1136-bmjopen-2017-019868.pdf220KbAdobe PDF421View/Open

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback